Tyra Biosciences (TYRA) News Today $15.87 -0.34 (-2.10%) (As of 11/20/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Post-Election Insider Buying in These 6 Stocks Is HugeNovember 17, 2024 | 247wallst.comTyra Biosciences, Inc. (NASDAQ:TYRA) Sees Significant Decrease in Short InterestNovember 17, 2024 | americanbankingnews.comTyra Biosciences (NASDAQ:TYRA) Stock Price Down 5% - Here's WhyTyra Biosciences (NASDAQ:TYRA) Stock Price Down 5% - Here's WhyNovember 15, 2024 | marketbeat.comTyra Biosciences, Inc. (NASDAQ:TYRA) Short Interest UpdateTyra Biosciences, Inc. (NASDAQ:TYRA - Get Free Report) was the target of a significant drop in short interest in October. As of October 31st, there was short interest totalling 1,760,000 shares, a drop of 20.0% from the October 15th total of 2,200,000 shares. Approximately 6.1% of the company's stock are sold short. Based on an average daily trading volume, of 294,700 shares, the days-to-cover ratio is currently 6.0 days.November 15, 2024 | marketbeat.comTyra Biosciences (NASDAQ:TYRA) Shares Gap Up - What's Next?Tyra Biosciences (NASDAQ:TYRA) Shares Gap Up - Time to Buy?November 14, 2024 | marketbeat.comTyra Biosciences to Present at Upcoming Investor ConferencesNovember 13, 2024 | prnewswire.comHC Wainwright Has Bearish Estimate for TYRA FY2024 EarningsTyra Biosciences, Inc. (NASDAQ:TYRA - Free Report) - HC Wainwright decreased their FY2024 EPS estimates for shares of Tyra Biosciences in a research note issued to investors on Monday, November 11th. HC Wainwright analyst M. Kapoor now expects that the company will post earnings per share of ($1.November 13, 2024 | marketbeat.comTyra Biosciences price target lowered to $29 from $31 at BofANovember 13, 2024 | markets.businessinsider.comKapoor’s Buy Rating Highlights Tyra Bioscience’s Promising Drug Developments and Strategic ExpansionNovember 11, 2024 | markets.businessinsider.comTyra Biosciences price target lowered to $30 from $32 at H.C. WainwrightNovember 11, 2024 | markets.businessinsider.comHC Wainwright Issues Pessimistic Forecast for Tyra Biosciences (NASDAQ:TYRA) Stock PriceHC Wainwright reduced their price target on Tyra Biosciences from $32.00 to $30.00 and set a "buy" rating for the company in a research report on Monday.November 11, 2024 | marketbeat.comTyra Biosciences’ Q3 2024: Clinical Progress and Financial ResilienceNovember 10, 2024 | markets.businessinsider.comTyra Biosciences Reports Third Quarter 2024 Financial Results and HighlightsNovember 7, 2024 | prnewswire.comInsider Selling: Tyra Biosciences, Inc. (NASDAQ:TYRA) Director Sells 1,076 Shares of StockNovember 7, 2024 | insidertrades.comAuour Investments LLC Reduces Position in Tyra Biosciences, Inc. (NASDAQ:TYRA)Auour Investments LLC trimmed its holdings in shares of Tyra Biosciences, Inc. (NASDAQ:TYRA - Free Report) by 75.3% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 21,020 shares of the company's stock after selling 64,000 shares durNovember 5, 2024 | marketbeat.comTyra Biosciences (NASDAQ:TYRA) Shares Gap Up Following Insider Buying ActivityTyra Biosciences (NASDAQ:TYRA) Shares Gap Up on Insider Buying ActivityNovember 4, 2024 | marketbeat.comChief Financial Officer of Tyra Biosciences Alan Fuhrman Buys 284% More SharesNovember 3, 2024 | finance.yahoo.comInsider Buying: Tyra Biosciences, Inc. (NASDAQ:TYRA) CFO Purchases 9,500 Shares of StockNovember 2, 2024 | insidertrades.comTyra Biosciences, Inc. (NASDAQ:TYRA) CFO Acquires $152,000.00 in StockTyra Biosciences, Inc. (NASDAQ:TYRA - Get Free Report) CFO Alan Fuhrman acquired 9,500 shares of the business's stock in a transaction on Wednesday, October 30th. The shares were purchased at an average price of $16.00 per share, for a total transaction of $152,000.00. Following the purchase, the chief financial officer now directly owns 12,849 shares of the company's stock, valued at $205,584. This represents a 200.00 % increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.November 1, 2024 | marketbeat.comTyra Biosciences (NASDAQ:TYRA) Shares Down 10.2% - What's Next?Tyra Biosciences (NASDAQ:TYRA) Stock Price Down 10.2% - Time to Sell?October 29, 2024 | marketbeat.comTyra Biosciences price target raised to $32 from $30 at H.C. WainwrightOctober 29, 2024 | markets.businessinsider.comTyra Biosciences granted IND clearance from FDA for Phase 2 study of Tyra-300October 29, 2024 | markets.businessinsider.comTyra Biosciences (NASDAQ:TYRA) Sees Strong Trading Volume After Analyst UpgradeTyra Biosciences (NASDAQ:TYRA) Sees Unusually-High Trading Volume After Analyst UpgradeOctober 28, 2024 | marketbeat.comHC Wainwright Raises Tyra Biosciences (NASDAQ:TYRA) Price Target to $32.00HC Wainwright increased their price target on shares of Tyra Biosciences from $30.00 to $32.00 and gave the company a "buy" rating in a report on Monday.October 28, 2024 | marketbeat.comTyra Biosciences Receives IND Clearance from FDA to Proceed with Phase 2 Study of TYRA-300 in Pediatric Achondroplasia (BEACH301)October 28, 2024 | prnewswire.comTyra Biosciences’ TYRA-300 shows anti-tumor activity in proof-of-concept trialOctober 25, 2024 | markets.businessinsider.comWhy Is Cancer-Focused Tyra Biosciences Stock Falling On Friday?October 25, 2024 | benzinga.comTyra Biosciences (NASDAQ:TYRA) Shares Gap Down - What's Next?Tyra Biosciences (NASDAQ:TYRA) Shares Gap Down - Here's WhyOctober 25, 2024 | marketbeat.comTyra Biosciences' (TYRA) "Outperform" Rating Reiterated at WedbushWedbush reiterated an "outperform" rating and set a $28.00 price target on shares of Tyra Biosciences in a report on Friday.October 25, 2024 | marketbeat.comTyra Biosciences Reports Interim Clinical Proof-of-Concept Data for TYRA-300, an Investigational Oral FGFR3-Selective Inhibitor, in Phase 1/2 SURF301 Study in Patients with Metastatic Urothelial Cancer (mUC)October 24, 2024 | prnewswire.comTyra Biosciences to Host Conference Call on Interim Clinical Data of TYRA-300 from SURF301 Phase 1/2 Study on October 25, 2024, at 8am ETOctober 23, 2024 | prnewswire.comTyra Biosciences (NASDAQ:TYRA) Sets New 52-Week High - Here's What HappenedTyra Biosciences (NASDAQ:TYRA) Hits New 1-Year High - What's Next?October 23, 2024 | marketbeat.comInsider Selling: Tyra Biosciences, Inc. (NASDAQ:TYRA) CEO Sells 19,084 Shares of StockOctober 23, 2024 | insidertrades.comTyra Biosciences (NASDAQ:TYRA) Shares Up 4.2% - Here's WhyTyra Biosciences (NASDAQ:TYRA) Trading 4.2% Higher - Should You Buy?October 21, 2024 | marketbeat.comTyra Biosciences: Upcoming FGFR3 Inhibitor Data Is A Major Inflection PointOctober 21, 2024 | seekingalpha.comAnalysts Offer Insights on Healthcare Companies: Supernus Pharmaceuticals (SUPN) and Tyra Bioscience (TYRA)October 19, 2024 | markets.businessinsider.comB of A Securities Upgrades Tyra Biosciences (TYRA)October 19, 2024 | msn.comBofA Upgrades Tyra Biosciences As Investors Focus On Preclinical Data Amid High Benchmarks Set By Johnson & Johnson's DrugOctober 19, 2024 | benzinga.comBank of America Upgrades Tyra Biosciences (NASDAQ:TYRA) to BuyBank of America upgraded shares of Tyra Biosciences from a "neutral" rating to a "buy" rating and boosted their target price for the stock from $22.00 to $31.00 in a report on Friday.October 18, 2024 | marketbeat.comTyra Biosciences, Inc. (NASDAQ:TYRA) CEO Sells $243,950.85 in StockOctober 18, 2024 | insidertrades.comInsider Selling: Tyra Biosciences, Inc. (NASDAQ:TYRA) CEO Sells 10,035 Shares of StockTyra Biosciences, Inc. (NASDAQ:TYRA - Get Free Report) CEO Todd Harris sold 10,035 shares of the business's stock in a transaction dated Tuesday, October 15th. The shares were sold at an average price of $24.31, for a total transaction of $243,950.85. Following the transaction, the chief executive officer now directly owns 1,467,338 shares of the company's stock, valued at $35,670,986.78. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.October 17, 2024 | marketbeat.comBoxer Capital, LLC Increases Stake in Tyra Biosciences IncOctober 16, 2024 | finance.yahoo.comTyra Biosciences (NASDAQ:TYRA) Hits New 1-Year High - Here's What HappenedTyra Biosciences (NASDAQ:TYRA) Sets New 12-Month High - What's Next?October 16, 2024 | marketbeat.comTyra Biosciences (NASDAQ:TYRA) Trading Up 5.4% - Here's What HappenedTyra Biosciences (NASDAQ:TYRA) Stock Price Up 5.4% - Here's WhyOctober 15, 2024 | marketbeat.comTyra Biosciences (NASDAQ:TYRA) Sees Unusually-High Trading Volume - Here's What HappenedTyra Biosciences (NASDAQ:TYRA) Sees Strong Trading Volume - Here's WhyOctober 14, 2024 | marketbeat.comTyra Biosciences Announces Late-Breaking Oral Presentation on Preliminary Safety and Anti-Tumor Activity of TYRA-300 from SURF301 at the 36th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics (ENA 2024)October 11, 2024 | prnewswire.comTyra Biosciences (NASDAQ:TYRA) Stock Price Down 4.9% - What's Next?Tyra Biosciences (NASDAQ:TYRA) Shares Down 4.9% - Should You Sell?October 9, 2024 | marketbeat.comTyra Biosciences CEO sells shares worth $12,000October 5, 2024 | uk.investing.comTyra Bioscience (TYRA) Receives a Buy from Piper SandlerOctober 3, 2024 | markets.businessinsider.comTyra Biosciences, Inc. (NASDAQ:TYRA) CEO Todd Harris Sells 500 SharesOctober 3, 2024 | insidertrades.com Get Tyra Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for TYRA and its competitors with MarketBeat's FREE daily newsletter. Email Address New Year, New Opportunity! 2 AI Stocks Under $10 Ready to Soar (Ad)As we step into 2025, artificial intelligence (AI) stocks continue to dominate headlines, and now is the perfect moment to position yourself for the coming year’s potential. Our latest research has uncovered two must-buy AI stocks currently trading under $10/share – an affordable entry with promising growth potential. These stocks are flying under the radar, but it’s only a matter of time before they gain mainstream attention. 👉 Click here to access your FREE report now! TYRA Media Mentions By Week TYRA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TYRA News Sentiment▼0.190.45▲Average Medical News Sentiment TYRA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TYRA Articles This Week▼63▲TYRA Articles Average Week Get Tyra Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for TYRA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies MLTX News HCM News AGIO News DYN News VRNA News PTCT News EWTX News BHC News XENE News MRUS News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:TYRA) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tyra Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tyra Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
